Oxidative stress level before and after supplement intake

Oxidative stress level before and after supplement intake - Supplement intake test

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032050

Enrollment

Registered

2018-04-06

Start date

2018-04-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma, cataract, diabetic retinopatyhy,central serus retinopathy

Interventions

Participants take 2 tablets in a day for eight weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Patients with Glaucoma, cataract, diabetic retinopathy, central serous chorioretinopathy. (2)glaucoma stage:from -2dB to -12dB according to MD. Diabetic retinopathy:NDR or SDR (3)BAP:from 1600 to 2100 nmol/L (4)dROMs: more than 300 CARR U (5)BMI:less than 25 kg/m2

Exclusion criteria

Exclusion criteria: (1)they have other ophthalmic conditions. (2)high myopia (3)LASIK (4)after surgery within three months (5)cancer (6)hypertension (7)autoimmune disease, thyroid disease (8)pill (9)other supplements (10)other clinical trial participants (11)allergic to supplement of this trial (12)pregnant woman

Design outcomes

Primary

Measure	Time frame
We focus on antioxidative potential, BAP level.	—

Secondary

Measure	Time frame
We investigate other oxidative stress level, dROMs, 8-OHsG, AGE, pentosidine(diabetic retinopatyhy), and glutathione.	—

Countries

Japan

Contacts

Public ContactNoriko Himori

Tohoku University Graduate School of Medicine Department of Ophthalmology

n-himori@oph.med.tohoku.ac.jp022-717-7294

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026